APstem Therapeutics, Inc.
About:
NOVEL STEM CELL TECHNOLOGY TARGETING UNMET MEDICAL NEEDS
Website: https://www.apstemtx.com/
Top Investors: InnoSpring Seed Fund, Beyond Ventures, Oriza Ventures, StartX (Stanford-StartX Fund), Magic Capital
Description:
With APstem Therapeutics’ breakthrough discovery of Adult Pluripotent Stem Cells (APSCs™), we are on a mission to eradicate difficult-to-heal diseases and conquer the challenges of aging.
Total Funding Amount:
$4.3M
Estimated Revenue Range:
$1M to $10M
Headquarters Location:
Fremont, California, United States
Founded Date:
2017-01-01
Contact Email:
info(AT)apstemtx.com
Founders:
Bowen Liu, Min Hu, Shaowei Li
Number of Employees:
1-10
Last Funding Date:
2020-09-01
IPO Status:
Private
Industries:
© 2025 bioDAO.ai